NEW YORK (GenomeWeb News) — Helicos BioSciences has begun manufacturing its Heliscope genome sequencer at its facility in Cambridge, Mass., the company said this week.
 
The company also said it is “approach[ing] receipt of our first commercial order.” It did not elaborate.
 
The company, which began trading on the Nasdaq exchange late last month, said it is expecting to launch the Heliscope late this year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligences for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.